| AUC (95% CI) | ||
---|---|---|---|
Study | Models | Men | Women |
Collins et al. (2010) [17] | Framingham risk score | 0.75 (0.747 to 0.753) | 0.774 (0.771 to 0.777) |
QRISK1® | 0.771 (0.768 to 0.774) | 0.799 (0.796 to 0.802) | |
QRISK2® | 0.773 (0.770 to 0.776) | 0.801 (0.798 to 0.804) | |
Collins et al. (2009) [25] | Framingham risk score | 0.752 (0.749 to 0.755) | 0.770 (0.766 to 0.774) |
QRISK1® | 0.762 (0.759 to 0.765) | 0.789 (0.785 to 0.793) | |
Hippisley-Cox et al. (2008) [18] | Framingham risk score | 0.779 (0.776 to 0.782) | 0.800 (0.797 to 0.803) |
QRISK1® | 0.788 (0.786 to 0.791) | 0.814 (0.811 to 0.817) | |
QRISK2® | 0.792 (0.789 to 0.794) | 0.817 (0.814 to 0.820) | |
Hippisley-Cox et al. (2007) [10] | Framingham risk score | 0.759 (0.756 to 0.764) | 0.774 (0.771 to 0.778) |
QRISK1® | 0.767 (0.763 to 0.772) | 0.788 (0.785 to 0.791) | |
ASSIGN | 0.764 (0.760 to 0.769) | 0.784 (0.781 to 0.787) |